In pet genetics, cancer research, and beyond, Charlie Lieu, MBA ’05, SM ’05, has spent her career harnessing massive data ...
Marcel Verbaas, Chairman and CEO, highlighted that "adjusted EBITDAre exceeded our expectations set at the beginning of the year as well as our more recent outlook." He noted total RevPAR growth of 8% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results